1. Home
  2. AAPG vs EYE Comparison

AAPG vs EYE Comparison

Compare AAPG & EYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascentage Pharma Group International American Depository Shares

AAPG

Ascentage Pharma Group International American Depository Shares

N/A

Current Price

$14.58

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Logo National Vision Holdings Inc.

EYE

National Vision Holdings Inc.

HOLD

Current Price

$16.59

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAPG
EYE
Founded
2009
1990
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2024
2017

Fundamental Metrics

Financial Performance
Metric
AAPG
EYE
Price
$14.58
$16.59
Analyst Decision
Strong Buy
Buy
Analyst Count
8
12
Target Price
★ $47.13
$28.18
AVG Volume (30 Days)
4.4K
★ 2.0M
Earning Date
08-19-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 202.78
EPS
N/A
★ 0.54
Revenue
N/A
★ $1,987,488,000.00
Revenue This Year
$21.37
$3.58
Revenue Next Year
$112.93
$5.10
P/E Ratio
★ N/A
$30.60
Revenue Growth
N/A
★ 9.00
52 Week Low
$14.55
$14.75
52 Week High
$40.23
$30.02

Technical Indicators

Market Signals
Indicator
AAPG
EYE
Relative Strength Index (RSI) 47.67 44.75
Support Level $14.55 $16.02
Resistance Level $16.18 $17.77
Average True Range (ATR) 0.40 0.62
MACD 0.07 0.12
Stochastic Oscillator 62.66 63.64

Price Performance

Historical Comparison
AAPG
EYE

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.

About EYE National Vision Holdings Inc.

National Vision Holdings Inc. is an optical retailer in the United States. Its product portfolio includes eyeglasses, sunglasses, contact lenses, accessories, and other related products. The company operates through a single operating segment. The Owned and Host segment includes the company-owned brands America's Best and Eyeglass World. In America's Best stores, vision care services are provided by optometrists or by independent professional corporations. The Host segment consists of Military and Fred Meyer locations, where eye exams are provided by independent optometrists.

Share on Social Networks: